Recent Finacing
Recent Raise
Regentis Biomaterials develops GelrinC, a resorbable hydrogel implanted as a liquid and cured in situ to support regeneration of articular knee cartilage, conducting multi-center clinical studies.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
